Based on the Quipt Home Medical Corp stock forecast from 2 analysts, the average analyst target price for Quipt Home Medical Corp is USD 6.50 over the next 12 months. Quipt Home Medical Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Quipt Home Medical Corp is Neutral, which is based on 9 positive signals and 8 negative signals. At the last closing, Quipt Home Medical Corp’s stock price was USD 2.41. Quipt Home Medical Corp’s stock price has changed by -5.86% over the past week, -9.40% over the past month and -51.21% over the last year.
No recent analyst target price found for Quipt Home Medical Corp
No recent average analyst rating found for Quipt Home Medical Corp
Company Overview Quipt Home Medical Corp
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky. Read Less
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical res...Read More
Frequently Asked Questions About Quipt Home Medical Corp (QIPT) Stock
Based on ratings from 2 analysts Quipt Home Medical Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 2 buy, sell and hold ratings.
Unfortunately we do not have enough data on QIPT's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for QIPT is USD 6.50 over the next 12 months. The maximum analyst target price is USD 7 while the minimum anlayst target price is USD 6.
QIPT stock's Price/Earning ratio is 468.00.
Our analysis grades QIPT stock's Price / Earning ratio at F. This means that QIPT stock's Price/Earning ratio is above 91% of the stocks in the Medical Devices sector in the NSD exchange.
Based on this QIPT may be a overvalued for its sector.
The last closing price of QIPT's stock was USD 2.41.
The most recent market capitalization for QIPT is USD 0.10B.
Based on targets from 2 analysts, the average taret price for QIPT is projected at USD 6.50 over the next 12 months.
This means that QIPT's stock price may go up by +169.71% over the next 12 months.
We can't find any ETFs which contains Quipt Home Medical Corp's stock.
As per our most recent records Quipt Home Medical Corp has 0 Employees.
Quipt Home Medical Corp's registered address is 1019 Town Drive, Wilder, KY, United States, 41076.
You can get more information about it from Quipt Home Medical Corp's website at https://quipthomemedical.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Quipt Home Medical Corp (QIPT) Stock
Based on ratings from 2 analysts Quipt Home Medical Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 2 buy, sell and hold ratings.
Unfortunately we do not have enough data on QIPT's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for QIPT is USD 6.50 over the next 12 months. The maximum analyst target price is USD 7 while the minimum anlayst target price is USD 6.
QIPT stock's Price/Earning ratio is 468.00.
Our analysis grades QIPT stock's Price / Earning ratio at F. This means that QIPT stock's Price/Earning ratio is above 91% of the stocks in the Medical Devices sector in the NSD exchange.
Based on this QIPT may be a overvalued for its sector.
The last closing price of QIPT's stock was USD 2.41.
The most recent market capitalization for QIPT is USD 0.10B.
Based on targets from 2 analysts, the average taret price for QIPT is projected at USD 6.50 over the next 12 months.
This means that QIPT's stock price may go up by +169.71% over the next 12 months.
We can't find any ETFs which contains Quipt Home Medical Corp's stock.
As per our most recent records Quipt Home Medical Corp has 0 Employees.
Quipt Home Medical Corp's registered address is 1019 Town Drive, Wilder, KY, United States, 41076.
You can get more information about it from Quipt Home Medical Corp's website at https://quipthomemedical.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for QIPT !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
